Compare VOC & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOC | SRTS |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8M | 44.3M |
| IPO Year | N/A | 2016 |
| Metric | VOC | SRTS |
|---|---|---|
| Price | $2.90 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 67.8K | 60.1K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 12.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | $6.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.60 | $2.66 |
| 52 Week High | $3.84 | $5.92 |
| Indicator | VOC | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 39.89 | 30.66 |
| Support Level | $2.71 | N/A |
| Resistance Level | $2.95 | $3.28 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 24.11 | 8.30 |
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust. It operates in a single operating and reportable segment.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.